LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PD173074 | 10 | uM | LJP6 | 2 | I07 | 72 | hr | 1694 | 6668 | 11309 | 0.5896 | 0.6491 |
MCF 10A | PD173074 | 10 | uM | LJP6 | 3 | I07 | 72 | hr | 1694 | 6623 | 11121 | 0.5955 | 0.6524 |
MCF 10A | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 1694 | 10901 | 11042 | 0.9872 | 0.9905 |
MCF 10A | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 1694 | 10927 | 11099 | 0.9845 | 0.9885 |
MCF 10A | Crizotinib | 0.04 | uM | LJP5 | 3 | A24 | 72 | hr | 1694 | 10810 | 11168 | 0.9679 | 0.9762 |
MCF 10A | Crizotinib | 0.12 | uM | LJP5 | 1 | A23 | 72 | hr | 1694 | 10498 | 11042 | 0.9507 | 0.9630 |
MCF 10A | Crizotinib | 0.12 | uM | LJP5 | 2 | A23 | 72 | hr | 1694 | 10513 | 11099 | 0.9472 | 0.9604 |
MCF 10A | Crizotinib | 0.12 | uM | LJP5 | 3 | A23 | 72 | hr | 1694 | 10636 | 11168 | 0.9523 | 0.9644 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 1 | A22 | 72 | hr | 1694 | 10034 | 11042 | 0.9087 | 0.9304 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 2 | A22 | 72 | hr | 1694 | 9918 | 11099 | 0.8936 | 0.9187 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 3 | A22 | 72 | hr | 1694 | 10017 | 11168 | 0.8969 | 0.9216 |
MCF 10A | Crizotinib | 1.11 | uM | LJP5 | 1 | A21 | 72 | hr | 1694 | 9726 | 11042 | 0.8808 | 0.9083 |
MCF 10A | Crizotinib | 1.11 | uM | LJP5 | 2 | A21 | 72 | hr | 1694 | 9742 | 11099 | 0.8777 | 0.9061 |
MCF 10A | Crizotinib | 1.11 | uM | LJP5 | 3 | A21 | 72 | hr | 1694 | 10001 | 11168 | 0.8955 | 0.9205 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 1 | A20 | 72 | hr | 1694 | 9094 | 11042 | 0.8236 | 0.8615 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 2 | A20 | 72 | hr | 1694 | 8909 | 11099 | 0.8027 | 0.8443 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 3 | A20 | 72 | hr | 1694 | 9028 | 11168 | 0.8084 | 0.8496 |
MCF 10A | Crizotinib | 10 | uM | LJP5 | 1 | A19 | 72 | hr | 1694 | 2091 | 11042 | 0.1894 | 0.0809 |
MCF 10A | Crizotinib | 10 | uM | LJP5 | 2 | A19 | 72 | hr | 1694 | 2233 | 11099 | 0.2012 | 0.1072 |
MCF 10A | Crizotinib | 10 | uM | LJP5 | 3 | A19 | 72 | hr | 1694 | 1985 | 11168 | 0.1777 | 0.0599 |
MCF 10A | BMS345541 | 0.04 | uM | LJP6 | 1 | D06 | 72 | hr | 1694 | 11096 | 11220 | 0.9889 | 0.9918 |
MCF 10A | BMS345541 | 0.04 | uM | LJP6 | 2 | D06 | 72 | hr | 1694 | 11260 | 11309 | 0.9956 | 0.9968 |
MCF 10A | BMS345541 | 0.04 | uM | LJP6 | 3 | D06 | 72 | hr | 1694 | 10906 | 11121 | 0.9807 | 0.9857 |
MCF 10A | BMS345541 | 0.12 | uM | LJP6 | 1 | D05 | 72 | hr | 1694 | 10692 | 11220 | 0.9529 | 0.9649 |
MCF 10A | BMS345541 | 0.12 | uM | LJP6 | 2 | D05 | 72 | hr | 1694 | 10851 | 11309 | 0.9595 | 0.9700 |